Investment firm Guggenheim initiated coverage of Teladoc with a buy rating.
Source
Guggenheim says Cathie Wood-favorite Teladoc can jump more than 40%
We want to boost our ownership of a portfolio stock that just boosted its dividend
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Thursday markets: Stocks are taking a breather after Wednesday’s big surge, especially in the Nasdaq Composite and the more narrow “Magnificent Seven” cohort. The yield on […]
Read MoreHealth care stocks fall as lawmakers, patients push for changes to their business models
UnitedHealth Group signage is displayed on a monitor on the floor of the New York Stock Exchange. Michael Nagle | Bloomberg | Getty Images Shares of major health-care companies fell as much as 5% on Wednesday as investors feared pressure from lawmakers and patients could force changes to their business models. The declining stocks include […]
Read MoreHealthy Returns: A huge deal to boost Novo Nordisk’s manufacturing is one step closer to closing
A view of the logo of Novo Nordisk at the company’s office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Tom Little | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. […]
Read More